About Index Trending news
Analyze
Pricing
Biotherapeutics

Biotherapeutics

Work at Biotherapeutics? Add yourself to this profile

Biotherapeutics

NIMML uses disruptive innovation to tackle global health challenges in infectious, immune-mediated & chronic inflammatory diseasesour site

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
Grant
$800,000
Virginia Catalyst
Venture capital
Employees

Unknown size

Locations
HQ
Headquarters
$300,000 Grant
vabio

Virginia Catalyst Awarded $2.825M in Grants to 6 Collaborative Projects - Virginia Bio

The Motley Fool

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today --

Stock markets
The Motley Fool

Why Atara Biotherapeutics Inc. Shares Are Getting Mauled Today --

Stock markets Health
$13,500,000 Venture capital (Series B)
Added by
via FinSMEs

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

$38,500,000 Venture capital (Series B)
Added by
via FinSMEs

Atara Biotherapeutics Secures $38.5M in Series B Financing